David P Luci's Net Worth
$6.5 Million
Who is David P Luci?
David P Luci has an estimated net worth of $6.5 Million. This is based on reported shares across multiple companies, which include Dipexium Pharmaceuticals, Inc., AMERI Holdings, Inc., ACCESS PHARMACEUTICALS INC, Acurx Pharmaceuticals, Inc., MACROCHEM CORP, and BIOENVISION INC.
SEC CIK
David P Luci's CIK is 0001271123
Past Insider Trading and Trends
2009 was David P Luci's most active year for acquiring shares with 6 total transactions. David P Luci's most active month to acquire stocks was the month of December. 2006 was David P Luci's most active year for disposing of shares, totalling 4 transactions. David P Luci's most active month to dispose stocks was the month of March. 2015 saw David P Luci paying a total of $397,250.00 for 35,000 shares, this is the most they've acquired in one year. In 2007 David P Luci cashed out on 310,154 shares for a total of $1,736,862.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dipexium Pharmaceuticals, Inc. No price found
President, CEO, Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17 - Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +0.11% | 2.08K |
$12.00 | $24,996.00 | 1.83M |
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMERI Holdings, Inc. (ENVB) Snapshot price: $0.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACCESS PHARMACEUTICALS INC (ABEO) Snapshot price: $5.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 263.22K |
$1.15 |
—
| 263.22K |
Feb 4 - Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acurx Pharmaceuticals, Inc. (ACXP) Snapshot price: $2.1
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +1.92% | 19.74K |
$3.55 | $70,066.35 | 1.05M |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +1.96% | 19.74K |
$3.80 | $75,000.60 | 1.03M |
Jul 27
| |||
Form 4
| +0.52% | 5.2K |
$4.80 | $24,960.00 | 1.01M |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29 - Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MACROCHEM CORP No price found
Pres. & Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 4
| +7.20% | 3K |
$0.59 | $1,770.00 | 44.67K |
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||